MorphoSys AG
MorphoSys AG (MPSYF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mpsyf · stock forecast · 7 analysts (3M) · FMP · updated Nov 18, 2025
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $73.27
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $72.83 | ↓ 0.60% |
1-day model range: $72.83–$72.83. Peak: $72.83 (-0.60%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MPSYF · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-10-12 | Morgan Stanley | Upgrade ↑ | Underweight→Overweight |
| 2023-09-14 | Goldman Sachs | Upgrade ↑ | Sell→Neutral |
| 2023-06-21 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-06-15 | JP Morgan | Upgrade ↑ | Underweight→Overweight |
| 2023-01-02 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
| 2022-11-17 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2022-01-13 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2021-08-05 | Deutsche Bank | Downgrade ↓ | Buy→Hold |
| 2021-06-10 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2021-06-02 | Bryan Garnier | Downgrade ↓ | Buy→Neutral |
Wall Street analysts have recently issued updated ratings on MorphoSys AG (MPSYF) stock. Of the recent 14 rating actions, 5 were upgrades and 6 were downgrades. 7 analysts currently cover MPSYF.
Analyst Recommendation Trends
MPSYF analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$303M
↓ 34.5% YoY
Revenue Next Year
$385M
↑ 27.3% YoY
EPS This Year
$-6.15
EPS Next Year
$-3.55
↓ 42.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast MPSYF EPS of $-6.15 for the current fiscal year, based on estimates from 1 analysts. The MPSYF revenue forecast is $303M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MPSYF stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MPSYF price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The MPSYF short-term stock prediction for tomorrow is $72.83 (-0.60%).
MorphoSys AG trades on OTC under the ticker MPSYF. The MPSYF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
MPSYF forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month MPSYF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $73.27.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.